Mackay Shields LLC Organon & Co. Transaction History

Mackay Shields LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$31.66 - $38.9 $1.13 Million - $1.39 Million	-35,640 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $45,949 - $59,394	-1,509 Reduced 4.06%	35,640 $1.25 Million
Q4 2021 Feb 04, 2022	SELL	$28.67 - $37.13 $22,563 - $29,221	-787 Reduced 2.07%	37,149 $1.13 Million
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $54,654 - $68,036	-1,909 Reduced 4.79%	37,936 $1.24 Million
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $1.13 Million - $1.51 Million	39,845 New	39,845 $1.21 Million

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.